MCKESSON CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 553.1 USD | -0.27% |
|
+1.69% | +19.87% |
| May. 09 | Deutsche Bank Adjusts Price Target on McKesson to $545 From $547 | MT |
| May. 09 | Wells Fargo Adjusts Price Target on McKesson to $551 From $502 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2025 * | 358B | Sales 2026 * | 383B | Capitalization | 72.09B |
|---|---|---|---|---|---|
| Net income 2025 * | 3.72B | Net income 2026 * | 3.9B | EV / Sales 2025 * | 0.2 x |
| Net Debt 2025 * | 230M | Net cash position 2026 * | 2.24B | EV / Sales 2026 * | 0.18 x |
| P/E ratio 2025 * |
19
x | P/E ratio 2026 * |
17.7
x | Employees | 48,000 |
| Yield 2025 * |
0.49% | Yield 2026 * |
0.52% | Free-Float | 46.73% |
More Fundamentals
* Assessed data
More news
Latest transcript on McKesson Corporation
More recommendations
More press releases
More news
| 1 day | -0.95% | ||
| 1 week | +3.97% | ||
| Current month | +3.24% | ||
| 1 month | +6.04% | ||
| 3 months | +9.87% | ||
| 6 months | +17.84% | ||
| Current year | +19.79% |
1 week
538.62
566.01
1 month
514.88566.01
Current year
462.70566.01
1 year
373.28566.01
3 years
184.43566.01
5 years
112.60566.01
10 years
106.11566.01
| Managers | Title | Age | Since |
|---|---|---|---|
Brian Tyler
CEO | Chief Executive Officer | 57 | 11-12-31 |
| Director of Finance/CFO | 55 | 18-01-26 | |
Francisco Fraga
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Donald Knauss
CHM | Chairman | 73 | 14-10-19 |
Webster Dunbar
BRD | Director/Board Member | 62 | 22-03-31 |
| Director/Board Member | 66 | 22-01-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.31% | 1,085 M€ | +7.96% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 555 | +0.07% | 88 254 |
| 24-05-13 | 554.6 | -0.95% | 683,349 |
| 24-05-10 | 559.9 | +0.86% | 636,900 |
| 24-05-09 | 555.1 | +2.12% | 977,354 |
| 24-05-08 | 543.6 | -0.39% | 1,378,615 |
Delayed Quote Nyse, May 13, 2024 at 04:00 pm EDT
More quotes
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
554.6
USD
Average target price
579.9
USD
Spread / Average Target
+4.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.79% | 72.09B | |
| -2.74% | 23.88B | |
| +10.27% | 8.89B | |
| +9.15% | 8.46B | |
| -17.39% | 8.29B | |
| +8.55% | 4.9B | |
| +17.69% | 4.34B | |
| -3.66% | 3.98B | |
| -2.47% | 3.89B | |
| +29.14% | 3.86B |
- Stock Market
- Equities
- MCK Stock